
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Stocks | 100.030 | 100.030 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 25.871 | 19.512 |
Price to Book | 3.407 | 2.610 |
Price to Sales | 2.567 | 1.807 |
Price to Cash Flow | 6.098 | 11.242 |
Dividend Yield | 0.155 | 0.963 |
5 Years Earnings Growth | 18.913 | 12.067 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 31.680 | 15.750 |
Industrials | 18.850 | 21.295 |
Technology | 14.960 | 19.720 |
Financial Services | 10.930 | 12.902 |
Consumer Cyclical | 10.220 | 12.140 |
Energy | 4.790 | 4.722 |
Communication Services | 4.100 | 2.926 |
Consumer Defensive | 3.180 | 3.849 |
Basic Materials | 1.300 | 4.446 |
Number of long holdings: 130
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Crinetics Pharma | US22663K1079 | 2.68 | 34.73 | -0.49% | |
Construction Partners | US21044C1071 | 2.47 | 71.33 | -0.83% | |
Alkami Technology | US01644J1088 | 1.76 | 26.41 | -1.71% | |
Modine Manufacturing | US6078281002 | 1.73 | 79.25 | -0.89% | |
Core Scientific | US21874A1060 | 1.63 | 7.480 | -5.08% | |
OneSpaWorld | BSP736841136 | 1.63 | 16.47 | -6.37% | |
Terawulf | US88080T1043 | 1.54 | 2.720 | -7.17% | |
Rhythm Pharma | US76243J1051 | 1.49 | 54.80 | +2.45% | |
Palomar | US69753M1053 | 1.39 | 136.77 | +0.12% | |
The Vita Coco Co Inc | - | 1.39 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
IE00BYZ09Q19 | 2.61B | 32.32 | 4.98 | - | ||
IE00BH4GYB17 | 1.34B | 4.77 | 4.44 | 10.16 | ||
IE00B61H9W66 | 381.63M | 1.64 | 3.33 | 8.30 | ||
IE00B94T1N53 | 381.63M | 1.64 | 3.33 | 8.30 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review